BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 15542448)

  • 1. Prolonged activation of tumor necrosis factor (TNF)-alpha and its soluble receptors in chronic heart failure patients both in the compensated and decompensated state. Interplay between their levels and metalloproteinase-3.
    Tziakas D; Chalikias G; Parissis JT; Hatzinikolaou H; Stakos D; Papadopoulou E; Kortsaris A; Hatseras D
    Eur Cytokine Netw; 2004; 15(3):231-9. PubMed ID: 15542448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus.
    Svenungsson E; Gunnarsson I; Fei GZ; Lundberg IE; Klareskog L; Frostegård J
    Arthritis Rheum; 2003 Sep; 48(9):2533-40. PubMed ID: 13130473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure.
    Wilson EM; Gunasinghe HR; Coker ML; Sprunger P; Lee-Jackson D; Bozkurt B; Deswal A; Mann DL; Spinale FG
    J Card Fail; 2002 Dec; 8(6):390-8. PubMed ID: 12528092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type D personality is associated with increased levels of tumour necrosis factor (TNF)-alpha and TNF-alpha receptors in chronic heart failure.
    Conraads VM; Denollet J; De Clerck LS; Stevens WJ; Bridts C; Vrints CJ
    Int J Cardiol; 2006 Oct; 113(1):34-8. PubMed ID: 16325284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing Type D personality and older age as correlates of tumor necrosis factor-alpha dysregulation in chronic heart failure.
    Denollet J; Vrints CJ; Conraads VM
    Brain Behav Immun; 2008 Jul; 22(5):736-43. PubMed ID: 18068948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma concentrations of TNF-alpha and its soluble receptors sTNFR1 and sTNFR2 in patients with coronary artery disease.
    Safranow K; Dziedziejko V; Rzeuski R; Czyzycka E; Wojtarowicz A; Bińczak-Kuleta A; Jakubowska K; Olszewska M; Ciechanowicz A; Kornacewicz-Jach Z; Machaliński B; Pawlik A; Chlubek D
    Tissue Antigens; 2009 Nov; 74(5):386-92. PubMed ID: 19845893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour necrosis factor receptors (TNFRs) in Type 2 diabetes. Analysis of soluble plasma fractions and genetic variations of TNFR2 gene in a case-control study.
    Vendrell J; Broch M; Fernandez-Real JM; Gutiérrez C; Simón I; Megia A; Gallart L; Ricart W; Richart C
    Diabet Med; 2005 Apr; 22(4):387-92. PubMed ID: 15787661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating tumor necrosis factor-alpha levels in chronic heart failure: relation to its soluble receptor II, interleukin-6, and neurohumoral variables.
    Koller-Strametz J; Pacher R; Frey B; Kos T; Woloszczuk W; Stanek B
    J Heart Lung Transplant; 1998 Apr; 17(4):356-62. PubMed ID: 9588580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease.
    Diniz BS; Teixeira AL; Ojopi EB; Talib LL; Mendonça VA; Gattaz WF; Forlenza OV
    J Alzheimers Dis; 2010; 22(4):1305-11. PubMed ID: 20930310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of Type D personality and kidney dysfunction as predictors of interpatient variability in inflammatory activation in chronic heart failure.
    Denollet J; Schiffer AA; Kwaijtaal M; Hooijkaas H; Hendriks EH; Widdershoven JW; Kupper N
    Am J Cardiol; 2009 Feb; 103(3):399-404. PubMed ID: 19166697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Activation and role of the tumor necrosis factor-alpha in congestive heart failure].
    Bachetti T; Comini L; Agnoletti L; Gaia G; Milanesi B; Curello S; Corti A; Ferrari R; Visioli O
    Cardiologia; 1996 Apr; 41(4):343-7. PubMed ID: 8674103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.
    Mahmoud RK; El-Ansary AK; El-Eishi HH; Kamal HM; El-Saeed NH
    Ital J Biochem; 2005; 54(3-4):248-57. PubMed ID: 16688934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of levels of matrix metalloproteinase-2 and -3 in patients with ischemic cardiomyopathy versus nonischemic cardiomyopathy.
    Tziakas DN; Chalikias GK; Papaioakeim M; Hatzinikolaou EI; Stakos DA; Tentes IK; Papanas N; Kortsaris A; Maltezos E; Hatseras DI
    Am J Cardiol; 2005 Nov; 96(10):1449-51. PubMed ID: 16275197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tumor necrosis factor alpha and its soluble receptors in serum of patients with coronary artery disease].
    Mizia-Stec K; Mandecki T; Zahorska-Markiewicz B; Janowska J; Szulc A; Jastrzebska-Maj E; Szymański L
    Pol Merkur Lekarski; 2001 Jul; 11(61):19-25. PubMed ID: 11579824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of treatment on soluble tumour necrosis factor receptor type 1 and 2 in chronic periodontitis.
    Ikezawa-Suzuki I; Shimada Y; Tai H; Komatsu Y; Tanaka A; Yoshie H
    J Clin Periodontol; 2008 Nov; 35(11):961-8. PubMed ID: 18823344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes of serum soluble P-selectin and tumor necrotic factor-alpha in patients with CMV induced acute coronary syndrome].
    Wang XM; Li Y; Huang C; Zhang RH; Guo HT; Chen H; Wang HC
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Jun; 19(2):149-51. PubMed ID: 16027783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased productivity of tumor necrosis factor-alpha in helper T cells in patients with systolic heart failure.
    Satoh S; Oyama J; Suematsu N; Kadokami T; Shimoyama N; Okutsu M; Inoue T; Sugano M; Makino N
    Int J Cardiol; 2006 Aug; 111(3):405-12. PubMed ID: 16271779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble tumour necrosis factor receptors sTNFR1 and sTNFR2 are produced at sites of inflammation and are markers of arthritis activity in Behçet's disease.
    Turan B; Pfister K; Diener PA; Hell M; Möller B; Boyvat A; Ergin S; Villiger PM
    Scand J Rheumatol; 2008; 37(2):135-41. PubMed ID: 18415772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body fat changes and activity of tumor necrosis factor α system--a 5-year follow-up study.
    Olszanecka-Glinianowicz M; Chudek J; Kocełak P; Szromek A; Zahorska-Markiewicz B
    Metabolism; 2011 Apr; 60(4):531-6. PubMed ID: 20580040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor-alpha-induced insulin resistance may mediate the hepatitis C virus-diabetes association.
    Knobler H; Zhornicky T; Sandler A; Haran N; Ashur Y; Schattner A
    Am J Gastroenterol; 2003 Dec; 98(12):2751-6. PubMed ID: 14687828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.